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Background & Aims 
Pancreatitis is characterized by increased influx of Ca2+ into acinar cells, by unknown 
mechanisms. Inhibitors of Ca2+ influx channels could be effective in treating acute pancreatitis, 
but these have deleterious side effects that can result in death. We investigated the expression 
patterns and functions of acinar cell Ca2+ channels and factors that regulate them during 
development of acute pancreatitis, along with changes in the channel inactivator store-operated 
calcium entry–associated regulatory factor (SARAF). We investigated whether SARAF is a target 
for treatment of acute pancreatitis and its status in human with pancreatitis. 
Methods 
We generated mice that expressed SARAF tagged with hemagglutinin, using CRISPR/Cas9 gene 
editing, and isolated acinar cells. We also performed studies with Saraf–/– mice, Saraf zf/zf mice, 
mice without disruption of Saraf (control mice), and mice that overexpress fluorescently labeled 
SARAF in acinar cells. We analyzed interactions between stromal interaction molecule 1 (STIM1) 
and SARAF in HEK cells stimulated with carbachol using fluorescence resonance energy transfer 
microscopy and immunoprecipitation. Mice were given injections of caerulein or L-arginine to 
induce pancreatitis. Pancreatic tissues and blood samples were collected and levels of serum 
amylase, trypsin, tissue damage, inflammatory mediators, and inflammatory cells were measured. 
We performed quantitative polymerase chain reaction analyses of pancreatic tissues from 6 organ 
donors without pancreatic disease (controls) and 8 patients with alcohol-associated pancreatitis. 
Results 
Pancreatic levels of Ca2+ influx channels or STIM1 did not differ significantly between acinar cells 
from mice with vs. without pancreatitis. By contrast, pancreatic levels of Saraf messenger RNA 
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and SARAF protein initially markedly increased but then decreased during cell stimulation or 
injection of mice with caerulein, resulting in excessive Ca2+ influx. STIM1 interacted stably with 
SARAF following stimulation of HEK or mouse acinar cells with physiologic levels of carbachol, 
but only transiently following stimulation with pathologic levels of carbachol, leading to excessive 
Ca2+ influx. We observed reduced levels of SARAF messenger RNA in pancreatic tissues from 
patients with pancreatitis, compared with controls. SARAF knockout mice developed more severe 
pancreatitis than control mice after administration of caerulein or L-arginine, and pancreatic acinar 
cells from these mice had significant increases in Ca2+ influx. Conversely, overexpression of 
SARAF in acini reduced Ca2+ influx, eliminated inflammation, and reduced severity of acute 
pancreatitis. 
Conclusions 
In mice with pancreatitis, SARAF initially increases but is then degraded, resulting in excessive, 
pathological Ca2+ influx by acinar cells. SARAF knockout mice develop more severe pancreatitis 
than control mice, whereas mice that express SARAF from a transgene in acinar cells develop 
less-severe pancreatitis. SARAF therefore appears to prevent pancreatic damage during 
development of acute pancreatitis. Strategies to stabilize or restore SARAF to acinar cells might 
be developed for treatment of pancreatitis. 
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Acute and chronic pancreatitis are inflammatory pathologies with no effective treatment1, 2. 
The multiple causes of pancreatitis are alcohol consumption, bile reflex, pancreatic duct 
obstruction, autoimmunity, genetic mutations and idiopathic causes3, 4. Pancreatitis is typified by 
altered CFTR localization and function in the duct5-7, increased systemic and pancreatic 
inflammatory mediators and tissue damage culminating in increased plasma amylase and lipase1, 
2. These result in injured acinar cells and destruction of the exocrine pancreas. Tissue and cellular 
analysis in animal models reveal that a major cause of pancreatitis is targeting of secretory 
granules with their digestive enzymes to the acidic lysosomes, activation of trypsin in acinar cell 
cytoplasm, and cell damage8, 9. A nodal point for all forms of pancreatitis is a prolonged, sustained 
increase in the concentration of free cytoplasmic Ca2+ ([Ca2+]i)10, 11. Indeed, preventing the Ca2+ 
increase in cellular12, 13 and animal models14-16 prevents the cell damage observed in acute 
pancreatitis. 
 
Sustained increase in [Ca2+]i requires activation of Ca2+ signaling. The physiological Ca2+ 
signal entails receptor-stimulated activation of phospholipase C and generation of IP3. IP3 
activates the IP3 receptors (IP3Rs), primarily at the apical pole of acinar cells to release a small 
fraction of ER Ca2+. Ca2+ release from the ER results in clustering of the ER Ca2+ sensor STIM1 
at the plasma membrane/endoplasmic reticulum (ER/PM) junctions, where it activates both the 
Ca2+ influx store-operated Orai1 channels17 and the TRPC channels18. The increase in [Ca2+]i 
activates the Sarcoplasmic/endoplasmic (SERCA) and plasma membrane (PMCA) Ca2+ ATPase 
pumps, which refill the ER with Ca2+ and clear cytoplasmic Ca2+, respectively. This cycle is 
repeated periodically, resulting in the physiological Ca2+ oscillations19.  
 
To prevent cell toxicity, it is critical to inhibit the Ca2+ influx channels, which initiates the phase 
of Ca2+ reduction in each Ca2+ spike during Ca2+ oscillations. Ca2+-dependent inhibition of Orai1 
has been studied extensively20. Orai1 activated by STIM1 undergoes two forms of inactivation. 
Fast Ca2+-dependent inactivation (FCDI) that is completed in about 100 milliseconds, and slow 
Ca2+-dependent inactivation (SCDI) that reduces channel current by about 80% within 2 minutes 
of channel opening20. Both, FCDI and SCDI are mediated by the Ca2+ influx channel regulatory 
protein SARAF (SOCE-associated regulatory factor)21-23.  
 
Acute pancreatitis caused by excessive Ca2+ influx can be treated by inhibition of Ca2+ influx 
channels or by increasing the activity of the Ca2+ influx channels inhibitor SARAF. We have 
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previously shown that genetic and pharmacological inhibition of TRPC channels prior to induction 
of acute pancreatitis effectively prevents the disease15. However, blocking TRPC channels after 
induction of acute pancreatitis fails to inhibit the disease. Pharmacological inhibition of Orai1 
partially protects against all models of acute pancreatitis tested, but targeted deletion of Orai1 in 
pancreatic acinar cells results in 70% mortality due to bacteremia and sepsis13, 16 24. Pancreatic 
acinar cells synthesize and secrete significant amounts of antibacterial agents to the gut to control 
the gut microbiota. Deletion of acinar cell Orai1 inhibits synthesis and secretion of the antibacterial 
agents to the gut, resulting in lethal dysbiosis24. An alternative approach is to target the regulator 
rather than the channels themselves. 
 
Here, we show that while SARAF interacted with STIM1 to limit Ca2+ influx during 
physiological stimulation, interaction of SARAF with STIM1 was transient during pathological 
stimulation of acinar cells, resulting in a sustained, toxic Ca2+ influx. Pathologic stimulation of 
acinar cells caused minimal change in the expression of various Ca2+ signaling proteins, including 
STIM1, over a time-course of 6 hrs. By contract, the mRNA and protein level of SARAF increased 
20-fold early during pathologic stimulation but then decreased in a time-dependent manner to very 
low level. Knockdown of SARAF in two mouse models markedly increased Ca2+ influx, 
mitochondrial Ca2+ accumulation, inflammation and severity of acute pancreatitis. Conversely, 
targeted transgenic expression of SARAF in mouse pancreatic acini reduced pathologic Ca2+ 
influx, prevented the inflammation and reduced tissue damage caused by induction of severe 
acute pancreatitis in two mouse models. These findings suggest that SARAF should be pursued 




Generation of SARAF knockout mice: SARAF knockout mice were generated using 
zinc finger nuclease mediated genome editing (Supplementary Fig. S1A). The zinc finger 
nuclease construct was custom designed by Sigma (Figs. S1A, lines A and B) and injected into 
the zygote embryos by the gene targeting core of NIDCR25. The embryos were planted in females 
with FVBNJ and C57bl6 background and the pups were screened for deletions in the genomic 
DNA. One mouse from each background was selected for breeding. The C57bl6 mice (line B) 
had deletion of 400 bases in the SARAF gene, resulting in a complete knockout. The FVBNJ mice 
(line A) had a 30 base-pair deletion at the start codon resulting in a truncated SARAF mouse line. 
The protocol for screening the mice is based on26 and the primers are listed in supplementary 
table 1.  The mutations and deletions were confirmed by amplifying and sequencing 1000-3000 
bases around the targeted sites. Briefly, the PCR product was TA cloned into pCR 2.1 vector from 
Invitrogen, transformed and 8 colonies were screened for each mouse. The sequences indicated 
that the mice were heterozygous for the mutations and were crossbred to obtain the knockouts.  
 
Generation of transgenic mice with targeted expression of SARAF-YFP in 
pancreatic acinar cells: Mice were generated using the rat elastase gene promoter (generously 
gifted by Dr. David Hui, University of Cincinnati) bases -500/+827. The elastase promoter was 
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cloned into EcoRI and BamH1 site of the pCMV6-AC-mYFP Tagged Cloning Vector (cat# 
PS100042) and mouse SARAF cDNA (accession # NM_026432) was inserted between the MluI 
and NotI sites. An EcoR1 site was engineered after the stop codon of YFP (Fig. S1B). The 
construct was digested and injected into zygote embryos of FVBNJ strain. Tail genomic DNA from 
littermates was screened for the construct by PCR and subsequent sequencing by TA cloning of 
the PCR product. Two positive mice were found, and one was propagated. Specific pancreatic 
expression was verified by RT-PCR (Fig. S1C). The transgene copy number was calculated using 
the protocol reported in28. Briefly, the concentration of genomic data was determined using Quant-
iT dsDNA Assay Kit (Invitrogen, cat. no. Q33130). Taqman probes (# Mm01197901) from 
Invitrogen was used for qPCR from the genomic DNA and the calculated copy number was 3. 
The SARAF transgenic mice are named SARAF/TG in the text and the Figures.   
 
Generation of endogenous HA-tagged SARAF mouse: SARAF was endogenously 
tagged with HA using CRISPR/Cas9. Guide RNA and donor plasmid was designed to target the 
last exon just before the stop codon (Table S1 and Fig. S1D). The donor plasmid and gRNA 
were co-injected in the mouse zygotes and implanted. The pups were screened for insertion of 
the HA tag with the primers in table S1. The PCR product generated 2000 bases upstream and 
downstream from the target site and TA cloned into pCR2.1 plasmid for sequencing. One of 6 
founders one was backcrossed to establish the mouse line. Expression of HA in various mouse 
tissues is shown in Fig. S1E. 
 
Preparation of Pancreatic acinar cells: Pancreatic acini were prepared from 3- to 6-
month-old mice as described previously24. Briefly, mice were sacrificed by CO2 inhalation, and 
the pancreas was removed and injected with cold solution A containing (mM): 140 NaCl, 5 KCl, 1 
CaCl2, 1 MgCl2, 10 pyruvate, 10 HEPES (pH 7.4, 310 mOsm), 0.1% bovine serum albumin, and 
0.02% soybean trypsin inhibitor. The tissue was finely minced and digested with collagenase P 
(0.25 mg/ml) dissolved in solution A. After washing twice, the acini were suspended in solution A 
without STI and were kept on ice until use. 
 
Measurement of cytoplasmic ([Ca2+]i) and mitochondrial ([Ca2+]m): [Ca2+]i was 
measured in acini loaded with Fura2 by incubation with 5 µM Fura2/AM (TEFLabs Inc., Austin, 
TX) and 0.05% Pluronic F-127 (Invitrogen, Carlsbad, CA) for 30 min at room temperature. 
Fluorescence was imaged with a TILL system at excitation wavelengths of 340 and 380 nm and 
emission above 500 nm was collected. [Ca2+]m was measured by loading the cells with Rhod2 by 
incubation with 8 µM Rhod2/AM (Life Technologies, Carlsbad, CA) and 0.05% Pluronic F-127 for 
15 min at room temperature. The acini were spun down and kept on ice for 30 min. Acini were 
plated on 0.01% poly-L-lysine coated cover slips and perfused continuously with solution A. 
Fluorescence was imaged at an excitation wavelength of 587nm with a 60X objective using an 
Olympus IX81 confocal microscope. Images were digitized at 2-s intervals and analyzed by 
MetaFlour software. 
 
Measurement of saliva secretion: 4-6-month-old mice were anesthetized by 
intramuscular injection of ketamine (60 mg/kg) and xylazine (8 mg/kg). Stimulated salivary 
secretion was initiated by injecting the mice subcutaneously with the indicated mg/kg pilocarpine, 
and saliva was collected every 5 min for 20-30 min into pre-weighted Eppendorf tubes by capillary 
drainage. The secreted saliva volume was normalized to body weight and averaged. 
 
Induction of acute pancreatitis: Acute pancreatitis was induced by two separate models, 
the caerulein and arginine models. Mild acute pancreatitis was induced by 7 hourly intraperitoneal 
injections of 10 µg/kg caerulein. Severe acute pancreatitis was induced by 8 or by 12 hourly 
injections of 40 µg/kg caerulein (AnaSpec Inc., Fremont, CA). Mice were euthanized 2 h after the 
last injection and blood and pancreas were collected. Severe acute pancreatitis was also induced 
by the arginine model29 as modified by 30. Mice were injected intra-peritoneally with 3g/kg of 20% 
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L Arginine solution every hour for 3 hours. Arginine solution was made in saline and filter sterilized. 
Control mice were injected with sterile saline (0.85% sodium chloride). The mice were kept on a 
heating pad in between the injections and for 4 hours after the last injection. The mice were 
euthanized after 72h. Collected blood serum was used to measure amylase and inflammatory 
mediators. The pancreatic tissue was collected and immediately embedded in OCT for 
hematoxylin and eosin(H&E) staining, evaluation of necrosis and immunohistochemistry. Tissue 
damage was analyzed as detailed before6. 
 
Measurement of serum amylase and amylase secretion: Blood samples were 
collected retro-orbitally from the mice and spun down at 1,000g. Amylase activity was measured 
in the cleared serum. Pancreatic acini were stimulated with 2 or 10 pM CCK-8 or various caerulein 
concentrations for 30 min at 37°C. The cells were centrifuged for 15 s at 5,000 rpm and the 
supernatants were collected. The secreted amylase was calculated as the percent of total 
amylase collected by lysing the cells and granules with 0.1% titox-x100. Amylase activity was 
measured with a Phadebas kit (Magle Life Sciences, Cambridge, MA) following the 
manufacturer’s instructions and as described before14.  
 
Measurement of trypsin activity: Trypsin activity was measure in pancreatic extracts 
prepared by homogenizing the tissue in 1x assay buffer provided in the kit from Abcam 
(ab102531). The assay was carried out according to the kit protocol. Briefly, 25 µl of supernatant 
was incubated with the provided trypsin substrate in a 96 well plate and absorbance was 
measured at 405 nm every 15 min up to 2 hours at 25 ºC. One unit of trypsin activity is defined 
as amount of trypsin that cleaves the substrate, yielding 1.0 μmol of p-NA per minute at 25°C. 
 
Measurement of necrosis: We used Oil red O stain to indirectly but more quantitively 
evaluate necrosis, similar to the procedure in31, 32. In brief, pancreatic sections were air dried for 
30 min and fixed in 10% formalin, washed twice in water and once in 60% isopropanol. Slides 
were stained by incubation for 10 minutes in Oil red O (Electron Microscopy Sciences, cat #26504-
01) and rinsed once in 60% isopropanol. The slides were counterstained with hematoxylin for 5 
min and washed in tap water for 10 min and were mounted using pure glycerol (Matsuda et al., 
2014). The area stained red was divided by the total area of the section to calculate % damage 
in each slide. Data was analyzed by MetaMorph software. 
 
Myeloperoxidase (MPO) assay: MPO activity was measured in pancreatic and lung 
extracts prepared from tissues homogenized in 1x assay buffer provided in the kit from BioAssay 
Systems, cat# EMPO-100. The samples were spun down and the supernatant was collected. The 
assay was in a 96 well plate following the manufacturer protocol and used 25 µl of the sample. 
Fluorescence was measured at excitation of 535 nm and emission of 585 nm at 0 and10 min time 
points. The activity was calculated as U/L where one unit of enzyme is defined as the amount of 
enzyme that catalyzes the formation of 1 µmole resorufin per min. 
 
Measurement of inflammatory markers: Serum samples were collected from the WT, 
SARAF-/- and pancreatic-targeted SARAF transgenic mice before and after inducing pancreatitis. 
The levels were measured using Luminex assay kit from EMD Millipore for inflammatory 
mediators (Mcytomag-70K) according to the manufacturer instructions and read on Biorad, Bio-
plex 200 system. 
 
Immunoﬂuorescence procedure: Frozen pancreatic tissue sections (8 µm thick) were 
fixed with cold methanol for 10 min at -20°C. After washing with PBS, the sections were blocked 
with 20% donkey serum (Jackson ImmunoResearch, West Grove, PA) for 30 min and incubated 
with primary antibodies: anti-neutrophil (Abcam, Cambridge, MA), anti-CD3 (Abcam, Cambridge, 
MA), anti-CD68 (Bio-Rad, Hercules, CA), and anti-mB220 (R&D systems, Minneapolis, MN) 
overnight at 4°C. The sections were incubated with the appropriate fluorescent tagged secondary 
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antibodies for an hour and were mounted in 40,6-diamidino-2-phenylindole (Electron Microscopy 
Sciences, Hatfield, PA). The stained tissue sections were imaged with Olympus confocal 
microscope model IX81 and inflammatory infiltrates were calculated using Volocity software 
version 6.3.0.  
 
Western blots and Co-IP: Protein expression of SARAF and co-immunoprecipitation of 
STIM1 and SARAF were determined in pancreatic acini from mice expressing SARAF-HA. For 
Western blots, after the indicated treatment, the acini were washed twice in PBS and lysed in 
cold-RIPA buffer (Cell Signaling, Danvers, MA) containing protease inhibitor (Roche, Basel, 
Switzerland). For co-immunoprecipitation, acini treated as indicated were lysed with ice-cold lysis 
buffer (10 mM Na3PO4, 137 mM NaCl, 2.7 mM KCl, 50 mM NaF, 1% Triton X-100, and protease 
inhibitor cocktail) and incubated on ice for 30 min. After brief sonication, lysates were centrifuged 
for 20 min at 14,000 rpm and quantified by Bradford protein assay (Bio-Rad, Hercules, CA). 
Lysates (300 µg protein) were incubated with anti-STIM1 antibodies (BD biosciences, San Jose, 
CA) overnight at 4°C and then protein G Sepharose beads (GE healthcare, Chicago, IL) were 
added and incubated for additional 3 h at 4°C. Beads were collected by brief centrifugation, 
washed three times with lysis buffer and proteins were released with sample buffer for separation 
by SDS/PAGE gel. Protein expression in mice pancreas was determined in SARAF-HA control 
mice and mice injected with 40g/kg caerulein twice or 8 times and sacrificed at 90 min and 9 
hours, respectively. The pancreata were collected, homogenized and lysed in RIPA buffer and 
the supernatants were collected for protein analysis. The blots were probed by anti-HA antibodies 
( cat # 3724S, Cell Signaling, Danvers, MA) and band densities were determined by Photoshop. 
 
FRET measurement: HEK293 cells were plated on glass bottom dishes (MatTek 
Corporation, Ashland, MA) and transfected with SARAF-YFP (acceptor) and STIM-CFP (donor)22, 
using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) and incubated for 18 hrs. FRET imaging 
was carried out using a confocal microscope (FV1000; Olympus) equipped with UplanSApo  60× 
oil immersion objective (NA 1.35; Olympus) at × 1 zoom. FRET signals were determined on a 
pixel-by-pixel basis using Fluoview 1000 software and data was analyzed using Microsoft excel. 
 
qPCR: Total mRNA was extracted using TRIZOL according to the manufacturer 
instructions (Invitrogen). The mRNA (2 µg) was reverse transcribed using cDNA synthesis kit (Life 
Technologies) with primers for quantitative RT-PCR for SARAF (Mm00509538_m1), STIM1 
(Mm01158413_m1), Orai1 (Mm07734349_m1), TRPC3 (Mm00444690_m1), TRPC1 
(Mm00441975_m1), TRPC6 (Mm01176083_m1) and GAPDH (Mm99999915_g1) purchased 
from Applied Biosystems. The fold change in transcript levels was calculated by normalizing the 
threshold values to GAPDH.  
Human pancreas mRNA was extracted from pancreatic tissue collected from volunteers 
after obtaining written consent at the Dept of Medicine, University of Szeged, Hungary. mRNA 
from pancreatic tissue of patient with pancreatitis from was either purchased from Origene 
(CR561065, CR561741, CR561222 and CR560152). Human pancreatic mRNA was also 
extracted from formalin fixed paraffin embedded samples collected at the Dept of Medicine, 
University of Szeged as part of pancreatitis analysis in patients. mRNA was extracted using the 
PureLink™ FFPE RNA Isolation Kit (K156002) and reverse transcribed to cDNA. The primers 
used for human beta actin (Hs01060665-g1) and SARAF (Hs00903199_m1) were purchased 
from Life technologies. The fold change in transcript levels was calculated by normalizing the 
threshold values to beta actin. 
 
Data mining and analysis: The gene expression omnibus (GEO) was searched for 
human and animal models with pancreatitis and RNA-seq results were found for 3 control and 
pancreatitis rats and for 3 health human controls and 9 humans with pancreatitis. The GEO was 
then searched for large datasets (>50 samples) containing data on gene expression in human 
pancreatic tissue, or in patients with pancreatic disease. Seven datasets were identified: 
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GSE16515, GSE15471, GSE28735, GSE55643, GSE74629, GSE77858, GSE62452, and 
GSE91035. Gene expression profiles were imported directly into Partek Genomics Suite, and 
log2 normalized data were analyzed using 1-way ANOVA with multiple test correction. Expression 
data for SARAF (TMEM66) were exported for all datasets with significant differential expression 
(false discovery rate, FDR<0.05) between control samples and disease samples and for rat and 
human pancreatitis, and graphs were created using Graphpad Prism software. 
 
Statistics: All experiments were repeated at least three times and all data were expressed 
as mean ± SEM. Statistical significance was determined by means of Student’s t test or ANOVA 







Ca2+ influx proteins and regulators in acute pancreatitis: To search for a potential cause 
for the pathogenic, uncontrolled Ca2+ influx in acute pancreatitis we used in vitro and in vivo 
physiological and pathological cell stimulation and determined the change in the level of the key 
TRPC and Orai1 Ca2+ influx channels and their regulators STIM1 and SARAF. Fig. 1A shows 
FRET measurements between STIM1-CFP and SARAF-YFP in transfected HEK cells stimulated 
with physiological (0.25 µM) and pathological (100 µM) carbachol. At physiological stimulation, 
SARAF interaction with STIM1 was maximal after 3 min and remained stable for the duration of 
cell stimulation. By contrast, at pathological stimulation STIM1-SARAF interaction was maximal 
at 2 min, did not attend the level measured with physiological stimulation, and then continually 
declined for the duration of cell stimulation.  
 
To determine if STIM1-SARAF interaction followed the same pattern in native pancreatic 
acinar cells, we tagged native mouse SARAF with HA using CRISPR/Cas9 gene editing (see 
methods and Supplementary Figs. S1D and S1E). Freshly isolated acini from these mice were 
stimulated with 0.1 or 100 µM carbachol for 0.5-10 min and the interaction of SARAF-HA and 
native STIM1 was measured by co-immunoprecipitation (Co-IP). Example blots and the summary 
of 4 experiments with cells obtained from 8 mice are shown in Fig. 1B. The pattern observed with 
the native proteins is the same as with the expressed proteins, indicating that pathological 
stimulation acutely disrupted the STIM1-SARAF interaction and suggested that this interaction 
that protects from excessive Ca2+ influx is lost early during physiological stimulation. 
 
In further analysis, we probed the mRNA levels of pancreatic acinar Ca2+ influx channels14, 
24, 33, 34, Stim1 and Saraf over 6 hrs in response to pathologic stimulation of isolated acini with 100 
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µM carbachol. The results in Figs. 1C and Fig. S2A show a slight or no increase in Orai1, Trpc1, 
Trpc3 and Trpc6 mRNA above baseline. Stim1 mRNA levels increased modestly within 1 hr of 
stimulation and remained elevated throughout. On the other hand, Saraf mRNA markedly 
increased in the first hour of stimulation but declined after 4 hours and was reduced by about 60% 
after 6 hours of stimulation. Next, we analyzed the level of SARAF-HA protein in isolated acini 
and in vivo. The sample blots and the averaged experiments with acini in Fig. 1D show that 
SARAF protein expression increased for the first hour of cell stimulation but was reduced to below 
the basal level after 2 hours of stimulation and more so after 4 hours of stimulation. Moreover, 
Fig. 1E shows that as early as 90 min after injecting mice with caerulein to induce acute 
pancreatitis pancreatic SARAF is nearly completely degraded and remained so after 8 caerulein 
injection, the time of fully developed severe acute pancreatitis. 
 
Relevance to human: To determine if changes in SARAF expression are relevant to human 
pancreatitis, first we searched the gene expression omnibus (GEO) for saraf mRNA in animal 
models and SARAF mRNA level in human. Fig. S2B shows results found for 3 control rats and 3 
rats with alcoholic pancreatitis and Fig. S2C shows the results for 3 healthy volunteers and for 9 
patients with various forms of pancreatitis. Although there is a clear trend of reduced SARAF in 
pancreatitis, false discovery rate (FDR) analysis failed to show statistical significance. Next, we 
searched for large data sets of more than 50 samples with pancreatic disease and focused on 
patients with pancreatic ductal adenocarcinoma (PDAC) because of the established connection 
between PDAC and pancreatitis35. The results in Fig. S2D shows significant reduction if SARAF 
mRNA in multiple data sets of patients with PDAC. Finally, we collected pancreatic mRNA from 
health volunteers and patients with pancreatitis and analyzed total hSARAF mRNA by qPCR. Fig. 
1F clearly show reduced hSARAF mRNA in pancreatitis. These findings point to the importance 
of SARAF both in human pancreatic cancer and pancreatitis.                   
 
The overall findings in Figs. 1 and S2 with mice and with human indicate that the function of 
SARAF, a major regulator of Ca2+ influx channels, is profoundly compromised during induction of 
acute pancreatitis. We next used knockout and transgenic mouse models to probe the 
physiological and pathological consequences of these findings.   
 
Knockout of SARAF in mice increases Ca2+ influx and alters Ca2+ signaling and cell 
function: To evaluate the role of SARAF in acute pancreatitis we generated two saraf knockout 
(Saraf -/-) mouse lines by Zinc Finger Nuclease (saraf zf/zf mice, supplementary Fig. S1A, lines A 
and line B). The effect of saraf knockout on Ca2+ signaling was tested in saraf zf/zf mice with similar 
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results obtained with lines B (Fig. 2) and A (Fig. S3). Figs. 2A and S3A show that deletion of saraf 
had minimal effect on ER Ca2+ content of pancreatic acinar cells, as evidenced by complete Ca2+ 
discharge upon inhibition of SERCA pumps with CPA, although a small but significant increase in 
ER Ca2+ was found in pancreatic acinar cells from saraf zf/zf line B (Fig. 2A). Stimulating the acini 
with 100 µM carbachol to trigger complete Ca2+ release showed similar results. No difference in 
the rate of Ca2+ clearance was observed between wild-type and Saraf -/- mice. However, receptor 
and store-operated (SOC) Ca2+ influx markedly increased in pancreatic acinar cells from the two 
saraf zf/zf mouse lines (Figs. 2A and S3A). 
 
As a consequence of markedly increased Ca2+ influx, the frequency of receptor-evoked Ca2+ 
oscillations was increased in Saraf -/- cells (Figs. 2C and S3C). In addition, deletion of Saraf 
increased mitochondrial Ca2+ content in resting pancreatic acinar cells (Figs. 2D, S3D and S3E). 
Mitochondrial Ca2+ content ([Ca2+]mito) was evaluated by treating acinar cells with the mitochondrial 
uncoupler tetrachlorosalicylanilide (TCS), which dissipates the mitochondrial membrane potential. 
Accordingly, after discharge of mitochondrial Ca2+ content, receptor stimulation had no further 
effect on [Ca2+]mito. The elevation in basal [Ca2+]mito content resulted in enhanced receptor-evoked 
[Ca2+]mito release (Figs. 2D and S3E). Receptor stimulation completely discharged [Ca2+]mito, as 
evident from the lack of effect of the TCS when added after carbachol. Finally, Fig. 3E shows that 
the increased Ca2+ influx, [Ca2+]mito and Ca2+ oscillations were translated to an enhanced amylase 
secretion stimulated with physiological agonist concentration. Furthermore, muscarinic 
stimulation of saliva secretion was higher in live Saraf -/- mice (Figs. 2F, S4) upon physiologic 
(0.05 and 0.25 mg/kg) but not pathogenic (0.5 mg/kg) receptor stimulation.       
 
Deletion of SARAF aggravates acute pancreatitis: The critical and common role of Ca2+ 
influx in multiple forms of acute pancreatitis1, 10, 11, prompted us to examine the effect of SARAF 
deletion on acute pancreatitis. We hypothesized that acute pancreatitis would be more severe in 
Saraf-/- mice. As expected, deletion of Saraf did not affect maximally severe acute pancreatitis 
induced by maximal concentrations of caerulein (not shown). By contrast, Saraf deletion caused 
higher increase in serum amylase when mild acute pancreatitis was induced using 10 µg/kg 
caerulein (Fig. 3A).  Moreover, Fig. 3B show significantly high basal pancreatic trypsin activity in 
Saraf-/- mice that did not increase further upon induction of mild acute pancreatitis and was higher 
than in WT with mild pancreatitis. Evaluation of necrosis by Oil red O staining31 showed a higher 
trend in the Saraf-/- mice (Fig. 3C). Tissue damage (Fig. 3E) and inflammation (Fig. 3F) were much 
more severe in in Saraf-/- mice. Fig. 3F shows an increase in basal serum IL-1α and IL-10 in the 
Saraf-/- mice. These cytokines and IL-6 increased minimally upon induction of mild acute 
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pancreatitis in WT mice but were markedly elevated in Saraf-/- mice (Fig. 3F). Analysis of 
inflammatory cells within the pancreas revealed markedly increased infiltration of neutrophils, 
macrophages, T cells and B cells in the pancreas of Saraf-/- mice (Fig. 3G, and example images 
in Fig. S5). Finally, increased IL6 is associated with increased lung injury36. Accordingly, Fig. 3D 
shows higher lung damage in Saraf-/- mice with acute pancreatitis.  
 
Targeted SARAF overexpression in pancreatic acini ameliorates severe acute 
pancreatitis: The dissociation of STIM1-SARAF interaction and dramatic reduction in SARAF 
levels in pancreatitis (Fig. 1), raised the question of whether maintaining high SARAF levels could 
reduce pathological Ca2+ influx and ameliorate acute pancreatitis. To examine this question, we 
developed transgenic mice with targeted overexpression of SARAF in pancreatic acini (refer to 
as SARAF/TG). Figs. 4A and 4B show that overexpression of SARAF in pancreatic acini had no 
measurable effect on ER Ca2+ content (CPA response) or Ca2+ release from the ER (carbachol 
response), but reduced Ca2+ influx by about 50%. The reduced Ca2+ influx resulted in decreased 
Ca2+ oscillation frequency (Fig. 4C), but the SARAF/TG acini were able to maintain normal 
mitochondrial Ca2+ content and response to receptor stimulation (Fig. 4D). The reduction in Ca2+ 
influx and Ca2+ oscillations by SARAF/TG acini caused reduction in exocytotic amylase release 
triggered by physiological receptor stimulation (Fig. 4E) and the inhibition of exocytosis by 
supramaximal receptor stimulation (Fig. 4F) that is associated with pancreatitis. 
 
Fig. 5 compares caerulein-induced severe acute pancreatitis in SARAF/TG mice and wild-
type littermates. Fig. 5A shows reduced serum amylase, and Figs. 5B and 5C show reduced 
pancreatic damage, in the SARAF-TG pancreas compared to wild-type mice. Most likely this was 
due to a profound reduction in inflammatory mediators in the SARAF/TG mice, which nearly 
completely suppressed the increase in M-CSF, TNF-α, IL-6 and IL-10 (Fig. 5D). Accordingly, 
pancreatic overexpression of SARAF reduced pancreatic infiltration of neutrophils, macrophages, 
T cells and B cells (Fig. 5E and Fig. S6).  
 
To extend h findings in Fig. 5 we tested if the SARAF/TG mice are protected when acute 
pancreatitis is induced by 12 caerulein injections and in an additional, independent model of acute 
pancreatitis, the L arginine model29. Fig. 6A shows reduced serum amylase and Fig. 6B shows 
reduced pancreatic trypsin activity in SARAF/TG mice injected with 12 times with caerulein 
compared with WT mice. The basal and 12 times caerulein-injected MPO level was lower in the 
SARAF/TG compared with WT mice. Analysis of serum amylase (Fig. 6D) and tissue injury (Fig. 
6E) in mice in which acute pancreatitis was induced by L arginine confirmed the protective effect 
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of SARAF in a second pancreatitis model. In addition, the SARAF/TG mice showed reduced 
pancreatic necrosis (Fig. 6F) and infiltration of T cells (Fig. 6G) and neutrophils (Fig. 6H) than WT 





Pancreatitis is a pathology with significant morbidity and mortality that damages the pancreas 
and has no effective treatment or cure3, 4. Acute pancreatitis involves the release of inflammatory 
mediators within the pancreas and subsequent acinar cell damage4. Chronic pancreatitis is 
caused by repeated severe or mild acute pancreatitis attacks1, 3. Acinar cell damage is a critical 
driver of acute and chronic pancreatitis. The pancreatic duct is the first line of defense37, 38, 
protecting the acini from damaging mediators by secreting HCO3--rich fluid37 . In all forms of 
pancreatitis, mislocalization and degradation of CFTR6 breaches the ductal guard, causing 
retention and activation of digestive enzymes within acinar cells and cell damage5-7.  
 
Pathologic sustained increase in [Ca2+]i is a prerequisite for aberrant exocytosis, causing 
targeting secretory granules to the lysosomes and activation of digestive enzymes within acinar 
cells in all forms of pancreatitis 1, 10, 11, 15. Numerous studies have shown that the sustained 
increase in cytoplasmic Ca2+ is due to uncontrolled Ca2+ influx. Although the cause of the 
increased Ca2+ influx has never been investigated,  inhibition of Ca2+ influx channels and loading 
acinar cells with cytoplasmic Ca2+ buffers (EGTA and BAPTA) have been used to demonstrate 
the role of elevated [Ca2+]i in cell damage and as potential treatments for pancreatitis12-16. 
However, usage of synthetic Ca2+ buffers is not a viable treatment option. Inhibition of Ca2+ influx 
TRPC channels proved ineffective when administered after induction of acute pancreatitis15. 
Inhibition of the main Ca2+ influx channel Orai1 is expected to have multiple side effects, since 
Ca2+ influx by Orai1 is essential for numerous cell functions and human mutations in Orai1 results 
in severe disease39. Although short term inhibition of Orai1 reduced the damage observed in acute 
pancreatitis16, short term deletion of Orai1 exclusively in pancreatic acini resulted in gut dysbiosis 
and death24. 
 
These observations and the discovery of dramatic changes in SARAF in the course of acute 
pancreatitis led us to reason that partial inhibition of all Ca2+ influx channels might be a better 
approach to control Ca2+ influx and pancreatic damage in acute pancreatitis. TRPC18 and Orai1 
channels39 are activated by STIM1. The SARAF protein interacts with STIM1 to mediate 
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inactivation of Orai121, 23 and likely TRPC channels40. A critical finding in Fig. 1 is that SARAF 
interaction with STIM1 is disrupted by pathological stimulation of acinar cells and that expression 
levels of SARAF change profoundly during pathological stimulation. Thus, pancreatic pathology 
is initiated by an early loss of protection by SARAF due to dissociation of SARAF from STIM1 to 
maintain Orai1 in a fully activate state and is exacerbated in later stages of the disease by nearly 
complete degradation of SARAF. Protection by SARAF appears to be important in both acute and 
chronic pancreatitis and is relevant to human, since reduction in SARAF mRNA is observed in 
human with pancreatitis and with PDAC. This also suggest that SARAF may have a role in 
pancreatic cancer. Together, these findings indicate that the most dramatic response of acinar 
cells to a pathological stimulus is an increase in SARAF transcription and translation, likely as a 
protection against Ca2+ toxicity. When this response breaks down pancreatitis develops. 
 
The loss of protection from excessive Ca2+ influx due to degradation of SARAF suggests that 
stabilizing and increasing SARAF expression should be a preferred approach to protecting 
against acute pancreatitis. This should restore the normal state of Ca2+ influx, rather than 
prominently disrupting channel activity that mediates numerous vital cellular functions. Deletion 
of SARAF in mice had no noticeable behavioral and physiological phenotype or pancreatic and 
salivary glands damage, although it enhanced fluid secretion and exocytosis in response to 
receptor stimulation. This suggests that SARAF functions mainly in the cell-active states. 
Accordingly, deletion of SARAF exacerbated acute pancreatitis and the inflammation associated 
with it. Therefore, the fairly mild effect of complete deletion of SARAF (present studies), compared 
to the severe effects of germline39 or pancreatic-specific deletion of Orai124, suggest that SARAF 
should be preferred target for treatment of acute pancreatitis. Moreover, stabilization of SARAF 
restores the basal state rather than removing essential function. The proof-of-concept that 
increasing SARAF expression could treat acute pancreatitis is evident from the effect of targeted 
expression of SARAF in the pancreas, which improved pathology in acute pancreatitis while 
nearly eliminating the inflammation associated with it. Taken together, our findings suggest that 
induced expression and stabilization of SARAF should be an attractive approach to treating acute 





Figure 1: STIM1-SARAF interaction and SARAF mRNA and protein in acute pancreatitis 
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(A) FRET was measured between STIM1-CFP and SARAF-YFP expressed in HEK cells together 
with M3 receptors and stimulated with 0.25 µM (black-physiological) or 100 µM (red-pathological) 
carbachol. The traces are the average of the indicated number of cells analyzed. (B) Pancreatic 
acini prepared from SARAF-HA expressing mice were stimulated with 0.1 or 100 µM carbachol 
and used to STIM1-SARAF interaction by Co-IP. Shown are example blots for acini obtained from 
SARAF-HA mice and from control (CTL) mice and the summary of 4 independent experiments. 
The (*) in the control lower blot mark a non-specific band (C) SARAF (red), STIM1 (blue), Orai1 
(green) and TRPC3 (black) mRNA levels normalized to GAPDH mRNA were determined by qPCR 
in acini stimulated for the indicated times in 5 independent experiments. (D) Pancreatic acini 
prepared from SARAF-HA expressing mice were stimulated with 100 µM carbachol for the 
indicated times and used to determine changes in SARAF protein. The Figure shows example 
blots and the numbers in the columns indicate the number of independent experiments. (E) Mice 
expressing SARAF-HA were injected with 40 µg/Kg caerulein 2 and 8 timed to initiate and develop 
fully blown acute pancreatitis, respectively. Mice were sacrificed 90 min after the second injection 
or 2 hrs after the 8th injection and the pancreas were rapidly removed to prepare lysates and 
analyze expression of SARAF. Shown are the blots and averages. (F) pancreatic tissue from 6 
health and 8 humans with pancreatitis was used to extract RNA and analyze SARAF mRNA. All 
averages are shown as mean±s.e.m. and in panels (B-F) the p values are listed.       
 
Figure 2: Ca2+ signaling and secretion in SARAF-/- mice (SARAFzf/zf mice, line B) pancreatic 
acini 
(A-B) Pancreatic acini from wild-type (black traces and columns) and SARAF-/- mice (red traces 
and columns) loaded with Fura2 and perfused with Ca2+-free solutions containing 0.2 mM EGTA 
were treated with 25 µM CPA (A) or 100 µM carbachol (B) and then exposed to solutions 
containing the indicated Ca2+ concentrations to evaluate Ca2+ release and Ca2+ influx. The traces 
and columns show the mean±s.e.m of the indicated number of cells from at least 4 independent 
experiments. (C) Fura2-loaded acini from wild-type and SARAF-/- mice were stimulated with 2 pM 
CCK-8 to evaluate the frequency of Ca2+ oscillations. (D) Pancreatic acinar cells from wild-type 
(black traces and columns) and SARAF-/- mice (red traces and columns) loaded with Rhod2 to 
evaluate mitochondrial Ca2+ concentration. The image shows typical Rhod2 loaded acini. The 
acini were treated first with the uncoupler TCS and then carbachol (upper traces and columns) or 
with carbachol and then TCS (lower traces and columns). (E)  Amylase secretion was measured 
in wild-type and SARAF-/- pancreatic acini stimulated with 10 pM CCK-8 for 30 min. The numbers 
in columns indicate the number of independent experiments. (F) Salivary secretion was measured 




Figure 3: Deletion of SARAF aggravates acute pancreatitis  
Mild acute pancreatitis was induced by 7 hourly intraperitoneal injection of 10 µg/Kg of caerulein. 
The control mice were injected with saline.  Severity of pancreatitis was evaluated by analysis of 
(A) serum amylase; (B) trypsin activity within the pancreas; (C) Necrosis using Oil red O staining; 
(D) MPO activity in lung tissue as a reporter of lung inflammation; (E) tissue damage by H&E 
staining; (F) serum inflammatory mediators IL-1α, IL-6 and IL-10 and (G) inflammatory cells within 
the pancreas, Neutrophils, macrophages (CD68), T cells (CD3) and B cells (B220). All incidence 
reports move severe acute pancreatitis in SARAF-/- mice.  
 
Figure 4: Ca2+ signaling and exocytosis in acini with targeted expression of SARAF in 
pancreatic acinar cells (SARAF/TG mice) 
(A-B) Pancreatic acini from wild-type (black traces and columns) and SARAF/TG mice (royal blue 
traces and columns) loaded with Fura2 and perfused with Ca2+-free solutions containing 0.2 mM 
EGTA were treated with 25 µM CPA (A) or 100 µM carbachol (B) and then exposed to solutions 
containing the indicated Ca2+ concentrations to evaluate Ca2+ release and Ca2+ influx. The traces 
and columns show the mean±s.e.m of the indicated number of cells from at least 4 independent 
experiments. (C) Fura2-loaded acini from wild-type and SARAF/TG mice were stimulated with 2 
pM CCK-8 to evaluate the frequency of Ca2+ oscillations. (D) Pancreatic acini from wild-type (black 
traces and columns) and SARAF/TG mice (royal blue traces and columns) were loaded with 
Rhod2 and treated with TCS and then carbachol (upper traces) or with carbachol and then TCS 
(lower traces). (E, F) Amylase secretion was measured in wild-type (black) and SARAF/TG 
pancreatic acini (royal blue) stimulated with 10 pM CCK-8 (E) or the indicated caerulein 
concentrations (F) for 30 min and released amylase was measured as % to total. The numbers in 
columns indicate the number of independent experiments.  
 
Figure 5: Targeted expression of SARAF in pancreatic acinar cells ameliorates severity of 
acute pancreatitis in the caerulein model.  
Severe acute pancreatitis was induced by 8 hourly intraperitoneal injection of 40 µg/Kg caerulein 
to WT (gray) or SARAF/TG mice (royal blue). Mice were scarified 2 hrs after the last injection and 
used to analyze (A) serum amylase, (B-C) tissue damage (B, example images and C averages), 
(D) serum inflammatory mediators MC-SF, TNF-α, IL-6 and IL-10 and (E) inflammatory cells within 




Figure 6: Targeted expression of SARAF in pancreatic acinar cells ameliorates severity of 
acute pancreatitis in caerulein and L arginine models.  
(A-C) Severe acute pancreatitis was induced by 12 hourly intraperitoneal injection of 40 µg/Kg 
caerulein to WT (gray) or SARAF/TG mice (royal blue). Mice were scarified 2 hrs after the last 
injection and used to analyze (A) serum amylase, (B) trypsin activity within the pancreas and (C) 
MPO within the pancreas as an indication of inflammation.  (D-H) Severe acute pancreatitis was 
induced by intraperitoneal injection of L arginine to WT (gray) or SARAF/TG mice (royal blue). 
Mice were used to analyze (D) serum amylase, (E) tissue damage, (F) necrosis, (G) infiltration of 




Supplementary Figure 1: Generation of SARAF knockout and transgenic mice 
(A) shows the site of the zinc finger-targeted deletion in line A (1-90 of exon 1) and line B (1-392 
of exons 1 and 2) and qPCR analysis of SARAF mRNA using the primers in table S1. (B) shows 
the design of the vector used to target expression of SARAF-YFP in pancreatic acini using the 
elastase promotor and (C) is qPCR analysis of SARAF/TG mRNA expression in various epithelial 
tissues showing exclusive expression in the pancreas. (D) Shows the site of insertion of the HA 
tag in the SARAF gene. (E) Western blot analysis of SARAF-HA in various tissues.  
 
Supplementary Figure 2: Effect of pancreatitis on pancreatic expression of mouse TRPC1 
and TRPC6, rat and human SARAF and SARAF in PDAC 
(A) Pancreatic acini were stimulated with 100 µM carbachol for the indicated times and Trpc1 and 
Trpc6 mRNA levels normalized to Gapdh mRNA were determined by qPCR in 5 independent 
experiments, as in Fig. 1C. Note the different mRNA scale in Fig. 1C and this Figure. (B) SARAF 
mRNA in control rats and rats with alcoholic pancreatitis (Data from xxx). (C) SARAF mRNA in 
patients with (red) and without (blue) pancreatitis (Data from xxx). (D) SARAF mRNA in patients 
with (red) and without (blue) PDAC (Results from the four indicated data sets). 
 
Supplementary Figure 3: Ca2+ signaling in SARAF-/- mice (line A) pancreatic acini 
 (A-B) Pancreatic acinar cells from WT (black traces) and Saraf-/- mice (red traces) loaded with 
Fura2 and perfused with Ca2+-free solutions containing 0.2 mM EGTA were treated with 25 µM 
CPA (A) or 100 µM carbachol (B) and then exposed to solutions containing the indicated Ca2+ 
concentrations. The traces show the mean±s.e.m of the indicated number of cells from at least 4 
independent experiments. (C) Fura2-loaded acini from WT and Saraf-/- mice were stimulated with 
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2 pM CCK-8 to induce Ca2+ oscillations. (D) Pancreatic acinar cells from WT (black traces and 
columns) and Saraf-/- mice (red traces and columns) loaded with Rhod2 were treated with TCS 
and then carbachol (D)  or with carbachol and then TCS (E).  
 
Supplementary Figure 4: Deletion of SARAF increases receptor stimulated salivation 
Salivary secretion was measured in 5 WT (black) and 5 Saraf-/- mice line B by application of 0.05 
mg/Kg pilocarpine + 0.02 mg/Kg isoproterenol; of 0.25 mg/Kg pilocarpine + 0.1 mg/Kg 
isoproterenol; or of 0.5 mg/Kg pilocarpine. Deletion of Saraf enhanced salivation at low and 
intermediate but not at maximal receptor stimulation. The results are mean±s.e.m and p values 
are given next to the symbols.  
 
Supplementary Figure 5: Example images of inflammatory cells in wild-type and SARAF-/- 
mice. 
The averages from multiple images are shown in Figure 3.  
 
Supplementary Figure 6: Example images of inflammatory cells in wild-type and 
SARAF/TG mice. 





Supplementary Table 1: Primers used for cloning, genotyping, sequencing of mouse lines. 
 
Transgenic elastase  
Saraf mice 
F :5’ GCTGGATGCAACTCAGCTGG 3’  




Saraf HA tagged mice F :5’ GGGTCTGCCTTGTTGGGTCTC 3’  
R :5’ GCGGTCTGTGCTCAGTCTCAG 3’  
 





















SARAF zinc finger nuclease 
mediated knockout 
on FVBNJ background 
 
F :5’ AGATTGGCGCAGGACAAAGT 3’  





SARAF zinc finger nuclease 
mediated knockout 
on C57bl6 background 
 
F :5’ GGCGGGCCCTTCCAGAATTTT 3’  






Saraf transgenic mice 
cloning primers 
F:5’ACGAATTCTATGAAAAAAAAAGCAATCCT    
    CACTCTTC 3’  
R:5’ACGGATCCCGAGACCACTGCCCCTTGC 
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